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Abstract
 
Tumor necrosis factor (TNF) signals cell death and simultaneously induces generation of cer-
amide. To evaluate the contribution of ceramide to TNF-dependent cell death, we generated
clones of the TNF-sensitive cell line L929 that constitutively overexpress human acid cerami-
dase (AC). Ceramidase, in concert with sphingosine kinase, metabolizes ceramide to sphin-
gosine-1-phosphate (SPP), an inducer of proliferation. In response to TNF, parental L929 cells
display a significant increase in intracellular ceramide correlated with an “atypical apoptosis”
 
characterized by membrane blebbing, DNA fragmentation and degradation of poly(ADP-
 
ribose) polymerase despite a lack of caspase activity. These features are strongly reduced or absent
 
in AC-overexpressing cells. Pharmacological suppression of AC with 
 
N
 
-oleoylethanolamine
restored the accumulation of intracellular ceramide as well as the sensitivity of the transfectants
to TNF, implying that an enhanced metabolization of intracellular ceramide by AC shifts the
balance between intracellular ceramide and SPP levels towards cell survival. Correspondingly,
inhibition of ceramide production by acid sphingomyelinase also increased survival of TNF-
treated L929 cells.
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Introduction
 
The sphingolipid ceramide has been described as an impor-
tant bioeffector molecule involved in cellular stress re-
sponses as well as in programmed cell death (for review see
references 1, 2), even though its relevance for apoptosis is a
controversial subject for discussion (3–7). Stress stimuli like
TNF, Fas ligand, oxidative stress, growth factor with-
drawal, anticancer drugs, ionizing radiation, heat shock, or
ultraviolet light induce an elevation in the endogenous cel-
lular levels of ceramide (1, 8). A function of endogenously
generated ceramide as a cofactor in the actions of stress
stimuli is supported by the ability of exogenous ceramide
analogues to mimic these biological responses in specific
cell types (1). Ceramide is generated from the major mem-
brane sphingolipid sphingomyelin by acid or neutral sphin-
 
gomyelinases (A- or N-SMases)
 
1
 
, enzymes that are acti-
vated in response to TNF and other cytokines (for review
see reference 9). The catabolic pathway for ceramide in-
volves deacylation by ceramidases to generate sphingosine,
which is phosphorylated by sphingosine kinase to form
sphingosine-1-phosphate (SPP). SPP in turn acts as a sec-
ond messenger in cellular proliferation and survival induced
by platelet-derived growth factor (PDGF) or serum (10).
Previously, a model has been proposed in which the dy-
namic balance between the intracellular levels of ceramide
and SPP (the “ceramide/SPP rheostat”) is an important
factor that determines whether a cell survives or dies (10).
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N
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mitoylsphingosine; DAPI, 4
 
9
 
,6-diamidino-2-phenylindole; NOE, 
 
N
 
-ole-
oylethanolamine; N-SMase, neutral sphingomyelinase; PARP, poly
 
(ADP-ribose) polymerase; SPP, sphingosine-1-phosphate; zDEVD-afc, ben-
 
zyloxycarbonyl-Asp-Glu-Val-Asp-aminotrifluoromethylcoumarin; zIETD-
afc, benzyloxycarbonyl-Ile-Glu-Thr-Asp-aminotrifluoromethylcoumarin;
zVAD-fmk, benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone. 
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According to this model, stress stimuli like TNF activate
SMases, leading to increased intracellular ceramide levels
and thus to increased cell death, whereas PDGF and other
growth factors stimulate ceramidase and sphingosine kinase
and elevate SPP levels, resulting in cellular survival and
proliferation (for review see reference 11).
Human acid ceramidase (AC) has recently been purified
and cloned (12, 13). Because ceramide degradation is the
only catabolic source of intracellular sphingosine (14), AC
activity may be the rate-limiting step in determining the
intracellular levels of sphingosine, and subsequently, SPP,
playing a crucial role for the status of the ceramide/SPP
rheostat and, in consequence, for cell survival or death in
response to external stimuli.
Here, we demonstrate that overexpression of AC in mu-
rine fibrosarcoma L929 cells protects against TNF-induced
cell death. Our results suggest that the enhanced expression
of AC results in a faster removal of intracellular ceramide and
therefore in a shift of the ceramide/SPP rheostat in the di-
rection of cell survival. Thus, in L929 cells, intracellular cer-
amide may be a major inducer of TNF-dependent cell death.
 
Materials and Methods
 
Plasmids and Reagents.
 
Highly purified human and murine
recombinant TNF was provided by Dr. G. Adolf (Bender
Research Institute, Vienna, Austria). The expression vector
pSV•SPORT1-AC, containing the full-length human AC
cDNA as well as the AC-specific rabbit polyclonal antiserum
have been described previously (12, 13). The L929 transfectant
clone Cl430 overexpressing Fas/APO-1 was provided by Dr. M.
Peter (Deutsches Krebsforschungszentrum [DKFZ], Heidelberg,
Germany). Collagen A was from Biochrom. 
 
N
 
-lauroylsphin-
gosine, 
 
N
 
-oleoylethanolamine (NOE), and 4
 
9
 
,6-diamidino-2-
phenylindole (DAPI) and desipramine were purchased from
Sigma-Aldrich. Benzyloxycarbonyl-Asp-Glu-Val-Asp-aminotri-
fluoromethylcoumarin (zDEVD-afc) and benzyloxycarbonyl-Ile-
Glu-Thr-Asp-aminotrifluoromethylcoumarin (zIETD-afc) were
ordered from Calbiochem. Benzyloxycarbonyl-Val-Ala-Asp-flu-
oromethylketone (zVAD-fmk) was obtained from Bachem, and
 
N
 
-palmitoylsphingosine (C
 
16
 
-ceramide) from Biomol. D609 was
purchased from MoBiTec and fumonisin B1 from Alexis Bio-
chemicals. The mAb CH-11 specific for human Fas/APO-1 was
purchased from Coulter/Immunotech. The monoclonal anti–
poly(ADP-ribose) polymerase (PARP) antibody C2-10, the
polyclonal Rho-GDI/D4-GDI antibody, and 7-amino-actino-
mycin D (7-AAD) were purchased from PharMingen. Antibod-
ies against caspase-3 (H-277) and lamin B (M-20) were from
Santa Cruz Biotechnology, Inc.
 
Cell Culture and Transfections.
 
L929 cells were originally ob-
tained from the American Type Culture Collection. Cells were
maintained in a mixture of Click’s/RPMI 1640 1:1 vol/vol) sup-
plemented with 10% vol/vol calf serum, 10 mM glutamine, and
50 
 
m
 
g/ml each of streptomycin and penicillin in a humidified in-
cubator containing 5% wt/vol CO
 
2
 
. Stably transfected L929 cells
expressing the full length AC cDNA were obtained by cotrans-
fection of pSV•SPORT1-AC with BMGNeo (15) using elec-
troporation at 960 
 
m
 
F/280 V and subsequent selection with
1,000 
 
m
 
g/ml Geneticin (Life Technologies). Transfectants ex-
pressing vector alone without insert were generated by cotrans-
fecting pSV•SPORT1 with BMGNeo. For the L929 clone
 
Cl430, expression of Fas/APO-1 on the cell surface was verified
in flow cytometry analyses.
 
Assays for Enzymatic Activity of AC. N
 
-[1-
 
14
 
C]lauroylsphingo-
sine was synthesized from [1-
 
14
 
C]lauric acid (CFA106; Amer-
sham Pharmacia Biotech; specific activity 2.0 GBq/mmol) and
sphingosine as previously described (16). 10
 
6
 
 cells were washed
with cold PBS, resuspended in 200 
 
m
 
l of cold lysis buffer (0.2%
vol/vol Triton X-100), left for 10 min on ice and homogenized
by repeated passing through a 25-gauge needle. After centrifuga-
tion, 100 
 
m
 
g of protein from the supernatant was added in dupli-
cates to a standard reaction mixture containing 150 
 
m
 
M 
 
N
 
-lau-
roylsphingosine, 2 
 
m
 
M 
 
N
 
-[1-
 
14
 
C]lauroylsphingosine, Triton X-100
(0.05% wt/vol), Tween 20 (0.02% wt/vol), NP-40 (0.04%
wt/vol), sodium cholate (0.08% wt/vol), and EDTA (5 
 
m
 
M) in
sodium acetate buffer (250 mM, pH 4.5) in a total volume of 100
 
m
 
l. The mixture was incubated for 1 h at 37
 
8
 
C, and the reaction
was stopped by the addition of 250 
 
m
 
l of H
 
2
 
O and 750 
 
m
 
l of
chloroform/methanol (2:1 vol/vol). After centrifugation, the
chloroform phase was evaporated under nitrogen. The extracted
lipids were separated by thin layer chromatography in chloro-
form/methanol/acetic acid (94:1:5 vol/vol/vol), visualized by
autoradiography and quantified in a PhosphorImager (Fuji). The
amount of protein added to the reaction mixtures was chosen so
that the reaction was linear within the time frame and the amount
of N-[1-
 
14
 
C]lauroylsphingosine hydrolyzed did not exceed 10%
of the total amount of radioactive substrate added.
 
Immunoblots and Generation of Cytosolic Cell Extracts.
 
Adherent
and detached cells were collected and lysed in TNE buffer (50
mM Tris, pH 8.0, 1% vol/vol NP-40, and 2 mM EDTA) con-
taining 10 
 
m
 
g/ml pepstatin/aprotinin/leupeptin, 1 mM sodium
orthovanadate, and 5 mM NaF. For detection of AC, 25 
 
m
 
g of
cell protein per lane were resolved by electrophoresis on 12.5%
wt/vol SDS-PAGE. After electrophoretic transfer to nitrocellu-
lose, reactive proteins were detected using AC-specific polyclonal
antibodies and the ECL detection kit (Amersham Pharmacia Bio-
tech). For detection of PARP, lamin B, D4-GDI, and caspase-3,
25 
 
m
 
g of protein was separated by SDS-PAGE on 8% (PARP)
or 12.5% gels and analyzed using the corresponding antibodies.
To generate cytosolic cell extracts (positive controls), cells were
lysed in a buffer containing 10 mM Hepes, pH 7.4, 142 mM
KCl, 5 mM MgCl
 
2
 
, 1 mM EGTA, 0.2% vol/vol NP-40, 1 mM
dithiothreitol, and 1 mM PMSF. The cell lysates were equili-
brated for 1 h at 30
 
8
 
C after the addition of 1 mM dATP and 10
 
m
 
M cytochrome c to permit activation of caspases and subsequent
cleavage of substrate proteins as previously described (17).
 
Cytotoxicity Assays.
 
10
 
4
 
 cells were seeded in flat-bottomed
96-well plates in medium containing serial dilutions of human (h)
or murine (m)TNF. After 48 h, cells were washed twice with
PBS and incubated for 10 min at 37
 
8
 
C in 50 
 
m
 
l of staining solu-
tion (crystal violet 0.5% wt/vol, formaldehyde 4% wt/vol, etha-
nol 30% vol/vol, and NaCl 0.17% wt/vol). The staining solution
was washed away with tap water and the cells were dried for 1 h
at 50
 
8
 
C. The stained cells were dissolved in acetic acid (33% vol/
vol) and the intensity of the staining was colorimetrically deter-
mined at 570 nm in a microplate reader (Dynex).
 
DAPI-Staining of Cells.
 
DAPI was dissolved in water at a
concentration of 10 mg/ml and stored at 4
 
8
 
C in the dark. 2 
 
3
 
10
 
4
 
 cells per well were grown on collagen A–coated chamber
slides (Nunc) and treated with either hTNF (100 ng/ml, 20 h) or
Fas/APO-1 antibody CH-11 (250 ng/ml, 10 h), or else left un-
treated. After removal of the culture medium, cells were washed
once in staining solution (500 ng/ml DAPI in methanol) and in-
cubated in staining solution for 15 min at 37
 
8
 
C. The cells were 
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washed once in methanol, dried, and photographed under a fluo-
rescence microscope (ZEISS Axioskop).
 
Hypodiploid Cell Assessment in Cell Cycle Analyses.
 
Adherent
and detached cells were collected and washed twice with cold
PBS/5 mM EDTA and resuspended in 1 ml PBS/5 mM EDTA.
Cells were fixed by dropwise addition of 1 ml ethanol and incuba-
tion at room temperature for 30 min, harvested, and resuspended
in 0.5 ml PBS/5 mM EDTA. After digestion with 20 
 
m
 
l RNAse
A (1 mg/ml) for 30 min at room temperature, cells were incu-
bated for 1 h in 0.5 ml of staining solution (500 
 
m
 
g/ml propidium
iodide in PBS/5 mM EDTA). Cell cycle analysis was performed
by flow cytometry using a FACSCalibur™ (Becton Dickinson).
 
Agarose Gel Electrophoresis for DNA Fragmentation.
 
10
 
6
 
 cells
were seeded into 10-cm dishes and grown for 48 h, while 100
ng/ml hTNF was added for 0, 20, and 48 h. Adherent and de-
tached cells were collected and resuspended in 20 
 
m
 
l of lysis
buffer (10 mM EDTA, 50 mM Tris, pH 8.0, 0.5% wt/vol so-
dium lauryl sarcosinate, 0.5 mg/ml proteinase K), incubated for
2 h at 50
 
8
 
C after addition of 5 
 
m
 
l RNAse A (1 mg/ml), and heated
to 65
 
8
 
C for 5 min before 10 
 
m
 
l of a mixture of gel-loading buffer
(25% wt/vol Ficoll 400 [Amersham Pharmacia Biotech], 25 mM
EDTA, and 0.5% wt/vol bromphenol blue, pH 8.0) and 1% low
melting point agarose (1:1 vol/vol, heated to 65
 
8
 
C) were added.
The heated samples were quickly transferred into dry wells of a
low melting point gel (2% wt/vol NuSieve GTG agarose), sepa-
rated electrophoretically, and visualized under UV light after
staining with ethidium bromide.
 
Fluorogenic Substrate Assay for Caspase Activity.
 
Cytosolic ex-
tracts from cells treated with hTNF or supplemented with dATP
and cytochrome c to activate caspases (positive control) were pre-
pared as described above. To measure caspase activity, 100 
 
m
 
l of
caspase buffer (20 mM Pipes, 100 mM NaCl, 10 mM dithiothre-
itol, 1 mM EDTA, 0.1% wt/vol CHAPS, and 10% wt/vol su-
crose, pH 7.2) containing 100 
 
m
 
M zDEVD-afc or zIETD-afc
were added to 5 
 
m
 
l of cytosolic extract (50 
 
m
 
g protein) and incu-
bated at 37
 
8
 
C. The release of afc was measured as emission at 510
nm upon excitation at 405 nm using a Labsystems Fluoroskan II
fluorimeter equipped with a thermostated plate reader.
 
Flow Cytometric Analysis of Membrane Integrity and Phosphati-
dylserine Externalization.
 
10
 
6
 
 adherent and detached cells were
collected, washed with cold PBS, and resuspended in 100 
 
m
 
l of a
buffer (10 mM Hepes, pH 7.4, 140 mM NaCl, and 5 mM CaCl
 
2
 
)
containing 2% vol/vol of Annexin V–FLUOS labeling reagent
(Boehringer Mannheim) and 20% vol/vol 7-AAD reagent
(PharMingen). The cells were incubated for 15 min in the dark at
room temperature and analyzed by flow cytometry using a FACS-
Calibur™ (Becton Dickinson). For permeabilization of cell
 
membranes with ethanol, 10
 
6
 
 cells were collected, washed with
cold PBS/5 mM EDTA, and resuspended in 1 ml PBS/5 mM
EDTA. Cells were fixed by dropwise addition of 1 ml ethanol
and incubation at room temperature for 30 min, then were col-
lected and stained as described above.
 
Ceramide Quantitation.
 
Ceramide was quantitated by the dia-
cylglycerol kinase assay essentially as described by Dressler and
Kolesnick (18), following the recommendations of Perry and
Hannun (5).
 
Measurement of Uptake of Exogenous Ceramide.
 
37 kBq (36.4
 
m
 
M) of 
 
14
 
C-labeled C
 
16
 
-ceramide (ARC-831; BIOTREND
Chemikalien GmbH; specific activity 2.03 GBq/mmol) were
added to 10
 
5
 
 cells followed by incubation for the indicated times
at 37
 
8
 
C. Next, the cells were washed two times with PBS and lysed
in 0.1% SDS. The incorporated radioactivity was determined by
scintillation counting.
 
Results
 
Generation of Stable Transfectants Overexpressing AC.
 
Pa-
rental L929 cells were stably transfected with pSV•SPORT1-
AC and Geneticin-resistant colonies were isolated. In addi-
tion, several transfectants were selected that contain the
expression vector pSV•SPORT1 without an insert. Of
those, clones pSV2 and pSV4, together with parental L929
cells, served as negative controls in the subsequent experi-
ments. Out of eight Geneticin-resistant clones displaying
an elevated level of AC activity, four (designated AC23,
AC28, AC33, and AC52) were chosen for further analysis.
The basal AC activities of clones AC23 to AC52 ranged
from 5- to 20-fold of those determined in parental L929
cells or in the control clones pSV2 and pSV4 (Fig. 1 A).
Western blot analyses using AC-specific antiserum con-
firmed corresponding increases at the level of AC expres-
sion (Fig. 1 B).
 
Reduced Cytotoxicity of TNF in AC-Overexpressing
Cells.
 
In the subsequent cytotoxicity assays, protein bio-
synthesis inhibitors were omitted to avoid nonspecific
effects. After treatment with hTNF, which binds to the 55-
but not to the 75-kD receptor of murine L929 cells, un-
transfected cells and control clones pSV2 and pSV4 were
efficiently killed at concentrations of 10–100 ng/ml hTNF
(Fig. 2 A). At the same concentrations, all AC-transfected
clones displayed a considerably higher viability (Fig. 2 B).
Figure 1. Activity and expression of AC
in stably transfected L929 clones. (A) En-
zymatic activity of AC in untransfected
L929 cells, in L929 cells transfected with
pSV•SPORT1 without insert (pSV2,
pSV4), and in L929 cells transfected with
pSV•SPORT1-AC (AC23 to AC52). The
values shown represent the means from
duplicate determinations. Similar results
were obtained in multiple independent ex-
periments (n 5 6–9 for each AC transfec-
tant). (B) Western blot analysis of AC ex-
pression in L929 transfectants. Purified a
and b subunits of AC as well as protein ex-
tracts from parental L929 cells, pSV2 and pSV4 cells, and clones AC23 to AC52 were immunoblotted using AC antiserum. The arrows indicate the
predicted sizes for mature AC (complex of a and b subunits) as well as for the individual subunits (a, 13 kD; b, 40 kD). 
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Treatment of the transfectants with mTNF, which engages
both the 55- and 75-kD TNF receptors (TR55 and TR75),
showed a similar protection of clones AC23 to AC52 at
concentrations of 3–30 ng/ml when compared with paren-
tal L929 cells or clones pSV2 and pSV4 (Fig. 2, C and D).
However, treatment with mTNF enhanced the overall
level of cell death in all cell lines. As stimulation of TR75
does not lead to activation of SMases and thus does not lead
to the production of ceramide (19), it appears likely that
TR75 elicits additional cytotoxic signals independent from
SMases or ceramide which in consequence cannot be com-
pensated by an enhanced enzymatic activity of AC.
 
TNF-induced Apoptosis in L929 Cells Shows Atypical Fea-
tures and Is Strongly Reduced in AC-transfected Cells.
 
We
compared changes in nuclear and cellular morphology of
untransfected and AC-overexpressing L929 cells by staining
with the DNA-specific dye DAPI. Untreated cells uni-
formly displayed an intact nuclear morphology with local-
ized patches of nuclear DNA (Fig. 3, A–E). Treatment
with hTNF led to a blebbing of the cell membranes culmi-
nating in the formation of chromatin-containing small ves-
icles indicative for apoptotic bodies in both untransfected
L929 cells and in pSV4 cells expressing empty vector (Fig.
3, F and G). Identical morphological changes were detect-
able in L929 cells stably transfected with human Fas/APO-1
(clone Cl430) that had been treated with Fas/APO-1 an-
tibody to induce apoptotic cell death (Fig. 3 J). In contrast,
only minor changes were visible in hTNF-treated clones
AC23 and AC52 (Fig. 3, H and I). Treatment with mTNF
elicited a greater number of dying cells in all cell lines when
compared with hTNF. Nevertheless, clones AC23 and
AC52 again were largely protected (data not shown). Of
note, we did not observe swelling of cells and rupture of
cell membranes that have been described as hallmarks of
necrotic cell death (20) in any of the above experiments.
However, as the morphological assessment of cells always
depends on the subjective interpretation of the viewer,
other, more objective parameters of cell death were ana-
lyzed subsequently.
In cell cycle analyses determining the degree of cellular
DNA fragmentation, a large fraction of hypodiploid L929
and pSV4 cells was detected after treatment with hTNF
(Fig. 4 A). In contrast, only a reduced number of hypodip-
loid cells was present in clones AC23 to AC52, indicating
that overexpression of AC also prevents DNA fragmenta-
Figure 2. AC-overexpressing L929 clones are protected from TNF-
induced cell death. Parental L929 cells and cells stably transfected with
AC (AC23 to AC52) or vector without insert (pSV2, pSV4) were treated
for 48 h with serial dilutions of hTNF (A and B) or mTNF (C and D) as
indicated. Cellular viability was determined by staining with crystal violet.
The values shown represent the means from six parallel determinations.
SD did not exceed 15% of the means.
Figure 3. Morphological changes in dying parental and stably trans-
fected L929 cells. Parental L929 cells, pSV4 cells, and clones AC23 and
AC52 were either left untreated (A–D) or treated with hTNF (100 ng/
ml, 20 h; F–I). In addition, clone Cl430 stably expressing human Fas/
APO-1 was left untreated (E) or stimulated with the monoclonal anti-
body CH-11 specific for human Fas/APO-1 (250 ng/ml, 10 h; J). Cells
were stained with the DNA-specific dye DAPI and photographed at an
original magnification of 400. 
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tion in response to hTNF. In parallel, cellular collapse was
monitored by determining changes in granularity and size
of the cells (Fig. 4 A, insets). Although a certain fraction of
collapsed cells could be observed in the AC-overexpressing
cell lines, it was dramatically less pronounced than the frac-
 
tion present in L929 or pSV4 cells treated with hTNF, in-
dicating that elevated AC activity does protect against the
cytotoxic signals of TR55, although not completely. These
results were confirmed in experiments analyzing DNA
fragmentation by agarose gel electrophoresis. As shown in
Fig. 4 B, treatment of L929 or pSV4 cells with hTNF in-
duced a readily visible oligonucleosomal fragmentation of
nuclear DNA indicative for apoptosis, whereas in clones
AC23 and AC52, the degree of DNA fragmentation was
much less pronounced.
During apoptosis, PARP, a DNA-associating nuclear
protein, is inactivated by processing of the mature 118-kD
protein to an 85-kD cleavage product (21). When L929 or
pSV4 cells were analyzed for PARP cleavage in Western
blots, the intensity of the uncleaved 118-kD band started to
decrease after 10 h of treatment with hTNF, resulting in
the disappearance of the uncleaved protein between 15 and
20 h (Fig. 5 A). Strikingly, the 85-kD band indicative for
cleavage by caspase-3 could not be detected, suggesting
that a protease different from caspase-3 is responsible for
the degradation of PARP in L929 cells. In contrast, no
degradation of PARP was evident in clones AC23 and
AC52 even after 20 h of hTNF treatment (Fig. 5 A).
When we examined cleavage of other caspase-substrate
proteins, neither lamin B, D4-GDI, nor caspase-3 itself
were cleaved or degraded after hTNF treatment for 20 h in
parental L929 cells (Fig. 5 B) or in clones AC23 and AC52
(data not shown). This argues that TNF does not activate
initiator caspases like caspase-8, -9, or -10 that induce
cleavage of the above substrate proteins in L929 cells.
However, by adding dATP and cytochrome c to the cell
lysates we could demonstrate cleavage of all substrate pro-
teins, confirming that the above caspases are present and
can be activated in L929 cells (Fig. 5 B, Co). The fact that
lamin B, D4-GDI, and caspase-3 were neither cleaved nor
degraded after treatment with hTNF indicates that the ob-
served degradation of PARP is not the result of a general
destruction of cellular proteins in the course of cell death.
Experiments determining cleavage of the fluorogenic
caspase-3 and -8 substrates zDEVD-afc and zIETD-afc
confirmed directly that hTNF induces neither caspase-3
nor -8 activity in L929 cells (Fig. 5 C).
The assumption that caspase-3 is not responsible for
PARP cleavage in L929 cells gained further support from
the observation that application of the broad-spectrum
caspase-inhibitor zVAD-fmk in combination with hTNF
did not inhibit PARP cleavage. On the contrary, zVAD-
fmk reduced the PARP degradation time dramatically to
 
,
 
6 h (Fig. 5 D).
We monitored the externalization of phosphatidylserine
and changes in plasma membrane integrity as further pa-
rameters of cell death. As a positive control for apoptotic
cell death, Jurkat cells were treated with Fas/APO-1 anti-
body, double-stained with annexin V and 7-AAD, and an-
alyzed by flow cytometry. As shown in Fig. 6 (top), the
cells displayed distinct populations of annexin V
 
1
 
/7-AAD
 
2
 
(early apoptotic; lower right quadrant) and double-positive
cells (late apoptotic/necrotic; upper right quadrant). In
Figure 4. DNA fragmentation in parental and AC-overexpressing
L929 cells. (A) Untreated L929 cells (top) or cells treated with 100 ng/ml
hTNF for 48 h (bottom) were stained for cell cycle analysis. The percent-
age of hypodiploid apoptotic cells is indicated. The corresponding density
plots of gated cells showing changes in granularity and cell size are indi-
cated to provide a second measure for cell death. The fraction of hypo-
diploid cells observed in untreated clones was ,0.8% (data not shown).
Similar results were obtained in four independent experiments. (B) Aga-
rose gel electrophoresis of genomic DNA from parental L929 cells, pSV4
cells, and clones AC23 and AC52 treated with 100 ng/ml hTNF for the
indicated times.606 Ceramidase Protects from Cell Death
contrast, parental L929 and pSV4 cells treated with hTNF
(middle) stained 7-AAD1/annexin V2 as early as 10 h (up-
per left quadrant of respective panels). However, no posi-
tive staining for annexin V was observed even after 48 h.
Only when L929 cells were actively permeabilized by
treatment with ethanol, a positive stain for both 7-AAD
and annexin V was detectable (bottom), arguing that phos-
phatidylserine is present but not externalized in hTNF-
treated L929 cells. Moreover, the positive staining with
7-AAD is not confirmatory for a necrotic loss of membrane
integrity since annexin V should also be able to enter the
cells. The AC-overexpressing clones showed a distinctly
reduced population of 7-AAD1/annexin V2 cells (AC23,
29%; AC52, 37% vs. L929, 64%; pSV4, 78%), confirming
protection against the cytotoxic effects of TNF (upper left
quadrant of respective panels).
In summary, the above results demonstrate that L929
cells show features of an atypical apoptosis in response to
TNF and that all of these features are strongly reduced or
prevented by overexpression of AC.
Overexpression of AC Prevents Generation of Intracellular Cer-
amide in Response to TNF. In analyses for changes in intra-
cellular ceramide levels, hTNF induced a marked increase
in both untransfected L929 cells and in the control clone
pSV4. In contrast, the intracellular ceramide content of
hTNF-treated clones AC23 and AC52 was essentially unal-
tered (Fig. 7). Apparently, the overexpression of AC does
not lead to a decrease of the basal intracellular ceramide lev-
els. As we detected most of the enzymatic activity of over-
expressed AC within the lysosomal fraction of the cells (data
not shown), it is plausible to assume that only ceramide gen-
erated within the endolysosome (e.g., by endolysosomal
acid sphingomyelinase) is accessible to the overexpressed
AC. These results clearly demonstrate an enhanced turnover
of newly generated ceramide in AC-overexpressing cells,
thereby explaining their enhanced protection against TNF-
induced cell death.
Exogenously Added C16-Ceramide but Not SMase Abrogates
Protection by AC. To determine whether the protective
effect of AC overexpression could be overcome by exoge-
nous ceramide analogues, parental and transfected L929
cells were treated with C2-ceramide (N-acetylsphingosine),
C6-ceramide (N-hexanoylsphingosine), or C16-ceramide.
C2-ceramide caused cell cycle arrest rather than cell death
(22), whereas C6- and C16-ceramide induced a dose-depen-
dent cell-death response without notable differences be-
tween parental and AC-overexpressing cells (Fig. 8 A and
data not shown). When we measured the uptake of exoge-
nous 14C-labeled C16-ceramide (Fig. 8 B), the amount in-
corporated within 2.5 h was more than 100-fold higher
than the amount of intracellular ceramide that is generated
in response to TNF (Fig. 7), indicating that even the en-
hanced capacity of the AC-overexpressing clones for cer-
amide degradation is overwhelmed by the massive influx of
exogenous C16-ceramide. When exogenous SMase from
Staphylococcus aureus (500 mU/ml) was added to parental
and transfected L929 cells, no signs of death or DNA frag-
mentation were detectable after 36 h, although the activity
of the enzyme was verified by demonstrating phosphoryla-
tion of p42/p44 extracellular-regulated kinase within 15
min (data not shown). These results are in agreement with
a recent study showing that exogenous SMase is not gener-
ally sufficient to induce cell death and that the generation
of ceramide intracellularly is distinct from generation of cer-
amide at the outer leaflet of the plasma membrane with re-
gard to cellular signaling (23).
Pharmacological Inhibition of AC Reduces Protection against
TNF-mediated Cell Death by Restoring Accumulation of Intra-
cellular Ceramide, Whereas Inhibition of A-SMase Increases
Protection. To extend the analysis of the mechanism by
which AC overexpression protects from cell death, paren-
tal and transfected L929 cells were treated with NOE, a
potent in vitro inhibitor of ceramidase (24). In parental
L929 or pSV4 cells, hTNF elicited a cytotoxic response
Figure 5. Caspase-3–indepen-
dent degradation of PARP in
L929 cells is prevented by over-
expression of AC. (A) Parental
and transfected L929 cells were
treated with 100 ng/ml hTNF
for the indicated times and ana-
lyzed for degradation of PARP.
(B) Parental L929 cells were left
untreated or treated with 100
ng/ml hTNF for 20 h and ana-
lyzed for cleavage of lamin B,
D4-GDI, caspase-3, and PARP.
Extracts from untreated cells that had been supplemented with
dATP and cytochrome c to induce caspase activity served as positive
controls (Co). (C) Parental L929 cells were treated with 100 ng/ml
hTNF for the indicated times, or caspase activity in untreated ex-
tracts was stimulated by the addition of dATP and cytochrome c.
Subsequently, caspase-3 and -8 activity was determined by measur-
ing the cleavage of fluorogenic substrates as described in Materials
and Methods. (D) Analysis of PARP degradation after treatment of
parental L929 cells with 100 ng/ml hTNF and 20 mM zVAD-fmk
for the indicated times. Arrowheads mark the sizes of the mature
proteins and their cleavage products.607 Strelow et al.
which was not enhanced further by addition of NOE.
Clones AC23 and AC52 showed protection against
hTNF-induced cell death which was clearly decreased
when hTNF was applied in combination with NOE (Fig.
9 A). When we measured the effect of NOE treatment on
intracellular ceramide levels of AC-overexpressing L929
cells, a clear increase was detected when clones AC23 and
AC52 were treated with NOE in combination with
hTNF (Fig. 9 B), explaining their enhanced sensitivity
seen in the corresponding cytotoxicity assays.
Parental L929 cells were treated with hTNF in the
presence of desipramine or of tricyclodecan-9-yl (D609).
Desipramine causes a rapid and irreversible reduction of
A-SMase activity by inducing proteolytic degradation of the
enzyme (25), whereas D609 prevents the TNF-dependent
activation of A-SMase (19). Compared with cells treated
with hTNF alone, both desipramine and D609 clearly in-
creased cell survival. In contrast, the ceramide synthase in-
hibitor fumonisin B1 had no protective effect, arguing that
TNF-induced accumulation of intracellular ceramide is me-
diated by A-SMase rather than by ceramide synthase (Fig. 9
C). Furthermore, demonstration of comparable TNF-depen-
dent decreases in cellular sphingomyelin content as well as
detection of essentially identical basal levels of A-SMase in
parental and transfected L929 cells showed that overex-
pressed AC protects clones AC23 and AC52 by removing
newly generated ceramide but not by interfering with cer-
amide generation through A-SMase (data not shown).
Discussion
Role of Ceramide in Cell Death. In this paper, the conse-
quences of AC overexpression and therefore of enhanced
metabolization of intracellular ceramide were investigated
with respect to TNF-induced cell death. Several lines of
evidence suggest that ceramide does not merely arise as a
consequence of apoptosis but rather contributes to cell
death itself (for review see references 1, 9). Lymphoblasts
from patients with Niemann-Pick disease, an inherited de-
ficiency of A-SMase, exhibit defects in their apoptotic re-
sponse to ionizing radiation which can be restored by retro-
viral transfer of human A-SMase cDNA. Similarly, A-SMase
knockout mice fail to generate ceramide and to develop
typical apoptotic lesions in the lung, but not in the thymus,
suggesting a tissue-restricted involvement of ceramide in
radiation-induced apoptosis (26). Moreover, resistance to
radiation-induced apoptosis in Burkitt’s lymphoma cells is
associated with defective ceramide signaling (27). Further
support for a role of ceramide in apoptosis comes from the
indirect manipulation of endogenous ceramide levels. Ad-
dition of either bacterial SMase or of inhibitors of ceramide
metabolism results in increased intracellular ceramide levels
and also in apoptosis (for review see reference 1). Finally,
numerous experiments have used synthetic short-chain cer-
amide analogues. However, these experiments should be
interpreted with caution. First, exogenous addition of cer-
Figure 6. Flow cytometric analysis of parental and transfected L929
cells double stained with 7-AAD and annexin V after treatment with or
without 100 ng/ml of hTNF for the indicated times (middle). The per-
centage of 7-AAD1/annexin V2 cells after 48 h of TNF treatment is in-
dicated. Jurkat cells were treated with Fas/APO-1 antibody (500 ng/ml)
as a positive control for apoptosis (top). In addition, parental L929 cells
were actively permeabilized by treatment with ethanol to verify the pres-
ence of phosphatidylserine at the inner cell membrane (bottom).
Figure 7. TNF-induced changes
of intracellular ceramide in pa-
rental and AC-overexpressing
L929 cells. Parental and trans-
fected L929 cells were treated
with 100 ng/ml hTNF for 20 h
before intracellular ceramide was
determined. Ceramide levels are
expressed relative to untreated
cells, in which basal ceramide was
between 50 and 180 pmol per
107 cells. The values shown rep-
resent the means from triplicate
determinations. Error bars indi-
cate the respective SDs. Similar
results were obtained in five in-
dependent experiments. Analysis of variance for repeated measurements
showed that ceramide levels in AC-overexpressing cells were significantly
different from those in parental or pSV4 cells (P , 0.001).608 Ceramidase Protects from Cell Death
amide analogues may not accurately mimic the transient
physiologic changes of ceramide levels within a cell. Second,
synthetic ceramide analogues may be metabolized to other
bioactive sphingolipids when added to intact cells. Our own
results demonstrate that in L929 cells short-chain exogenous
C2-ceramide analogues or SMase do not accurately mimic
the effects of intracellular ceramide elicited by TNF. In con-
trast to synthetic ceramide analogues, inhibitors, or bacterial
SMase, the overexpression of AC used in this study permits a
direct evaluation of the effects of an enhanced ceramide me-
tabolism. The results obtained by this approach strongly sug-
gest that in L929 cells the enhanced expression of AC di-
rectly leads to a faster removal of intracellular ceramide
generated in response to TNF and thereby to the observed
protection from TNF-induced cell death, further supporting
a role for ceramide in cell death.
Atypical Apoptosis in L929 Cells. The murine fibrosar-
coma cell line L929 represents one of the few systems in
which TNF induces cell death in the absence of inhibitors
Figure 8. Protection of AC-overexpressing cells is overcome by ex-
ogenously added C16-ceramide. (A) Parental and transfected L929 cells
were incubated with the indicated concentrations of C16-ceramide for 7 h
(top) or 16 h (bottom) and stained for cell cycle analysis. The percentage
of hypodiploid apoptotic cells is indicated. (B) Parental and transfected
L929 cells were incubated with 14C-labeled C16-ceramide for the indi-
cated times and uptake of exogenous C16-ceramide was measured. The
values shown represent the means from triplicate determinations. Error
bars indicate the respective SDs.
Figure 9. Pharmacological inhibition of AC diminishes protection
from TNF-induced cell death, whereas inhibition of A-SMase enhances
protection. (A) Parental and transfected L929 cells were incubated with or
without 100 mM NOE in the presence of 100 ng/ml hTNF for 48 h. (B)
Clones AC23 and AC52 were treated with 100 ng/ml hTNF with or
without 100 mM NOE for 40 h before intracellular ceramide was deter-
mined. (C) Parental L929 cells were treated with or without 25 mM de-
sipramine or 25 mg/ml D609 in the presence of 100 ng/ml hTNF for
48 h. Separately, L929 cells were incubated with 100 ng/ml hTNF for 48 h
with or without addition of 50 mM fumonisin B1. Cell viability is ex-
pressed relative to untreated controls. Ceramide levels are expressed rela-
tive to untreated cells, in which basal ceramide was between 100 and 120
pmol per 107 cells. Values shown represent the means from three or six
parallel determinations (ceramide levels or cell viability), and error bars
indicate the respective SDs. *P , 0.002 versus cells not treated with
NOE (determined by Student’s t test). One out of three independent ex-
periments with similar results is shown.609 Strelow et al.
of protein biosynthesis. Therefore, L929 cells have been
widely used as a model system to study TNF-dependent
cell death. However, the current literature is inconsistent
with regard to the exact mode of death induced by TNF in
this cell line. Several studies describe necrotic death of
L929 cells treated with TNF (28, 29), whereas other groups
have observed apoptotic cell death (22, 30, 31). A possible
solution to these divergent results may come from the ex-
planation that most studies describing necrotic death of
L929 cells have been performed with a subclone of L929
cells, L929sA (Vandenabeele, P., personal communication).
L929sA has been selected for high TNF-sensitivity (32) and
therefore may show responses different from those of pa-
rental L929 cells when undergoing cell death.
Consistent with our own results, Fady et al. reported
both chromatin condensation and DNA laddering in TNF-
treated L929 cells, which indicates apoptosis. Moreover, cell
shrinkage characteristic for apoptosis was observed in both
our experiments (Fig. 4 A) and those of Fady et al., whereas
balloon-type degeneration of TNF-treated L929 cells typi-
cal for necrosis was not detected (30). Additionally, Haya-
kawa et al. describe membrane blebbing in TNF-treated
L929 cells, similar to our own data shown in Fig. 3 (22).
However, there are also observations suggesting that apop-
tosis takes an “atypical” course in TNF-treated L929 cells.
First, in agreement with reports of a delayed appearance of
DNA fragmentation (30), we could detect only minor
amounts of hypodiploid L929 cells at ,20 h of hTNF treat-
ment in cell cycle analyses (our unpublished data). Second,
we and others have observed an early increase of cells stain-
ing positive for DNA-specific dyes like 7-AAD or propid-
ium iodide after treatment with TNF (see Fig. 6 and refer-
ences 30, 33). Although this increase has been interpreted as
an early loss of plasma membrane integrity and therefore
necrosis (33), our own data show that annexin V is unable
to gain entry unless the cells are actively permeabilized, ar-
guing that the increased staining for propidium iodide and
7-AAD does not reflect a general leakiness of the cell mem-
brane typical for necrotic cell death but may perhaps repre-
sent a process of selective uptake. In addition, our data
demonstrate that although phosphatidylserine is present at
the inner membrane of L929 cells, it is not externalized after
treatment with TNF, a response untypical for apoptosis (see
Fig. 6). Third, Fadeel et al. have recently shown that exter-
nalization of phosphatidylserine occurs in a cell type-specific
manner and is furthermore dependent on the activity of
caspases (34). In agreement with this requirement, we were
unable to detect activation of caspase-3 or -8 in response to
hTNF, suggesting that neither initiator caspases nor execu-
tor caspases are activated by hTNF in L929 cells. Neverthe-
less, the capability of L929 cells to activate caspase-3 and -8
could very well be demonstrated by the addition of dATP
and cytochrome c to cell extracts. These data are in line
with observations by Vercammen et al., who similarly did
not find an increase of caspase-3– and -1–like activities after
TNF-treatment of L929 cells (Fig. 5 and reference 28). Our
results indicate that unlike cell systems such as 293 human
embryonal kidney cells, where liberation of ceramide is reg-
ulated by caspases (35), the generation of ceramide by TNF
occurs altogether independently from caspases in L929 cells.
In consequence, the observed degradation of PARP may be
carried out by a protease different from the above caspases.
The fact that activation of this protease by hTNF was pre-
vented in L929 cells overexpressing AC argues that this
protease is directly or indirectly activated by ceramide. Fur-
thermore, the fact that treatment of L929 cells with the
caspase-inhibitor zVAD-fmk did not prevent but rather ac-
celerated PARP-degradation strongly suggests that caspase
activity is not crucial or may not be required at all for apop-
tosis in L929 cells. This absence of caspase activation in re-
sponse to TNF makes L929 cells a tool especially suited to
study the contribution of ceramide to TNF-induced apop-
tosis. L929 cells may represent a biological system in which
a nontypical form of apoptosis occurs in response to TNF,
leading to classic morphological alterations like membrane
blebbing and disintegration into apoptotic vesicles but also
comprising atypical symptoms like delayed DNA fragmen-
tation and lack of caspase activation.
Ceramide As a Potential Mediator of Caspase-Independent
Apoptosis. Caspase-independent apoptosis has also been
described for PML-induced death of rat embryo fibroblasts,
death of activated T cells through CD2 and staurosporine,
and for the Fas-mediated death of Jurkat cells in the pres-
ence of peptide inhibitors for caspase-3–like enzymes (36–
38). In the latter case, cell death was characterized by cell
shrinkage and surface blebbing, but lacked features like
chromatin condensation and DNA fragmentation. In con-
trast, DNA fragmentation occurs in L929 cells, although
delayed, suggesting multiple forms of apoptosis, either
caspase-dependent or –independent with cell type–depen-
dent fluent transitions between the individual forms. This
may provide the cells of an organism with more flexibility,
e.g., in combating infections by viruses that inhibit caspase-
dependent apoptosis.
One mechanism by which caspase-independent apopto-
sis occurs may involve perturbations of mitochondria (37).
As mitochondria represent a target for intracellular cer-
amide, this sphingolipid may be part of an alternative, poten-
tially ancient cellular mechanism by which a cell can react
to infections or other insults. The relevance of ceramide in
this process is supported by the observation that overex-
pression of Bcl-2, which blocks the effects of ceramide on
mitochondria, also protects L929 cells from death after
treatment with TNF (39). Furthermore, Jayadev et al. have
demonstrated that in L929 cells, TNF induces a 2.5-fold
increase in intracellular ceramide within 24 h (correspond-
ing to our own data shown in Fig. 7) with a concomitant
activation of SMases preceding the onset of cell death,
whereas a TNF-resistant L929 subline was deficient in cer-
amide generation (40). Correspondingly, pharmacological
inhibition of A-SMase by two different inhibitors acting
through independent mechanisms clearly increased the sur-
vival of parental L929 cells after treatment with TNF (see
Fig. 9 C). Analogous to our own results obtained with
AC-transfected cells, overexpression of glucosylceramide
synthase, an enzyme that converts ceramide to glucosylcer-610 Ceramidase Protects from Cell Death
amide, also conferred resistance to cell death induced by
ceramide or adriamycin (41).
In summary, the results obtained by stably overexpress-
ing AC in L929 cells indicate an important role of ceramide
in the initiation of cell death. In some cell types, ceramide
may act as a cofactor contributing to caspase-dependent cell
death. In other cell types, ceramide may be entirely re-
placed by caspases. In yet other cell types, e.g., in L929
cells, ceramide may constitute an important inducer of cell
death. The proapoptotic function of ceramide can appar-
ently be regulated or attenuated at multiple checkpoints
along the apoptotic signaling pathway. The data presented
in this study strongly suggest that AC represents one of
these checkpoints. In support of this hypothesis, intracellu-
lar ceramide levels can be controlled by regulating the ac-
tivity of ceramidases such as AC. In primary rat hepato-
cytes, IL-1b stimulates ceramidases at low concentrations
(,4 ng/ml) and inhibits them at higher concentrations. In
this system, regulation of ceramidase activity may provide a
“switch” controlling sphingolipid levels and thus multiple
intracellular responses (42). Furthermore, nitric oxide in-
hibits ceramidases in renal mesangial cells while simulta-
neously stimulating SMases. This results in a chronic up-
regulation of intracellular ceramide preceding apoptosis and
may be physiologically important in the resolution of
glomerulonephritis (43). It is highly likely that checkpoints
for ceramide accumulation like AC work in a cell type–
specific manner. Therefore, although the generation of cer-
amide contributes to cell death, the decision whether a spe-
cific cell dies or not is probably made at the level of activity
of control mechanisms such as AC.
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